{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T23:10:07Z","timestamp":1747177807156,"version":"3.40.5"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T00:00:00Z","timestamp":1417651200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00213-014-3823-8","type":"journal-article","created":{"date-parts":[[2014,12,3]],"date-time":"2014-12-03T01:01:19Z","timestamp":1417568479000},"page":"1911-1920","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The separate and combined effects of monoamine oxidase inhibition and nicotine on P50 sensory gating"],"prefix":"10.1007","volume":"232","author":[{"given":"Dylan M.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Blier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vadim","family":"Illivitsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verner","family":"Knott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,4]]},"reference":[{"key":"3823_CR1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0006-3223(92)90073-9","volume":"32","author":"LE Adler","year":"1992","unstructured":"Adler LE, Hoffer LJ, Griffith J, Waldo MC, Freedman R (1992) Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol Psychiatry 32:607\u2013616","journal-title":"Biol Psychiatry"},{"key":"3823_CR2","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1176\/ajp.150.12.1856","volume":"150","author":"LE Adler","year":"1993","unstructured":"Adler LE, Hoffer LD, Wiser A, Freedman R (1993) Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry 150:1856\u20131861","journal-title":"Am J Psychiatry"},{"key":"3823_CR3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/npp.1994.28","volume":"10","author":"LE Adler","year":"1994","unstructured":"Adler LE, Hoffer L, Nagamoto HT, Waldo MC, Kisley MA, Giffith JM (1994) Yohimbine impairs P50 auditory sensory gating in normal subjects. Neuropsychopharmacology 10:249\u2013257","journal-title":"Neuropsychopharmacology"},{"key":"3823_CR4","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1176\/appi.ajp.161.10.1822","volume":"161","author":"LE Adler","year":"2004","unstructured":"Adler LE, Olincy A, Cawthra EM, McRae KA, Harris JG, Nagamoto HT et al (2004) Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients. Am J Psychiatry 161:1822\u20131828","journal-title":"Am J Psychiatry"},{"key":"3823_CR5","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1176\/appi.ajp.162.2.386","volume":"162","author":"LE Adler","year":"2005","unstructured":"Adler LE, Cawthra EM, Donovan KA, Harris JG, Nagamoto HT, Olincy A, Waldo MC (2005) Improved p50 auditory gating with ondansetron in medicated schizophrenia patients. Am J Psychiatry 162:386\u2013388","journal-title":"Am J Psychiatry"},{"key":"3823_CR6","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/0006-3223(95)00084-4","volume":"38","author":"I Berlin","year":"1995","unstructured":"Berlin I, Said S, Spreux-Varoquaux O, Olivares R, Launay JM, Puech AJ (1995a) Monoamine oxidase A and B activities in heavy smokers. Biol Psychiatry 38:756\u2013761","journal-title":"Biol Psychiatry"},{"key":"3823_CR7","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0009-9236(95)90058-6","volume":"58","author":"I Berlin","year":"1995","unstructured":"Berlin I, Sa\u00efd S, Spreux-Varoquaux O, Launay JM, Olivares R, Millet V et al (1995b) A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers. Clin Pharmacol Ther 58:444\u2013452","journal-title":"Clin Pharmacol Ther"},{"key":"3823_CR8","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0022-3565(25)24852-2","volume":"237","author":"P Blier","year":"1986","unstructured":"Blier P, De Montigny C, Azzaro AJ (1986) Modification of serotonergic and noradrenergic neurotransmissions by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat central nervous system. J Pharmacol Exp Ther 237:987\u2013994","journal-title":"J Pharmacol Exp Ther"},{"key":"3823_CR9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.psychres.2004.01.007","volume":"126","author":"NN Boutros","year":"2004","unstructured":"Boutros NN, Korzyukov O, Jansen B, Feingold A, Bell M (2004) Sensory gating deficits during the mid-latency phase of information processing in medicated schizophrenia patients. Psychiatry Res 126:203\u2013215","journal-title":"Psychiatry Res"},{"key":"3823_CR10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0161-813X(03)00107-4","volume":"25","author":"K Castagnoli","year":"2004","unstructured":"Castagnoli K, Murugesan T (2004) Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson\u2019s disease and neuroprotection; are there links? NeuroToxicology 25:279\u2013291","journal-title":"NeuroToxicology"},{"key":"3823_CR11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/sj.npp.1301421","volume":"33","author":"PA Csomor","year":"2008","unstructured":"Csomor PA, Stadler RR, Feldon J, Yee BK, Geyer MA, Vollenweider FX (2008) Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. Neuropsychopharmacology 33:497\u2013512","journal-title":"Neuropsychopharmacology"},{"key":"3823_CR12","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1176\/ajp.155.11.1490","volume":"155","author":"GW Dalack","year":"1998","unstructured":"Dalack GW, Healy DJ, Meador-Woodruff JH (1998) Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am J Psychiatry 155:1490\u20131501","journal-title":"Am J Psychiatry"},{"key":"3823_CR13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0893-133X(98)00121-3","volume":"21","author":"GW Dalack","year":"1999","unstructured":"Dalack GW, Becks L, Hill E, Pomerleau OF, Meador-Woodruff JH (1999) Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia. Neuropsychopharmacology 21:195\u2013202","journal-title":"Neuropsychopharmacology"},{"key":"3823_CR14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neuroscience.2013.03.029","volume":"241","author":"S Salle de la","year":"2013","unstructured":"de la Salle S, Smith D, Choueiry J, Impey D, Philippe T, Dort H, Knott V (2013) Effects of COMT genotype on sensory gating and its modulation by nicotine: differences in low and high P50 suppressors. Neuroscience 241:147\u2013156","journal-title":"Neuroscience"},{"key":"3823_CR15","volume-title":"Structured Clinical Interview for DSM-IV: non-patient Version","author":"M First","year":"1995","unstructured":"First M, Spitzer R, Williams J, Gibbon M (1995) Structured Clinical Interview for DSM-IV: non-patient Version. American Psychiatric, Washington, DC"},{"key":"3823_CR16","doi-asserted-by":"crossref","first-page":"11600","DOI":"10.1073\/pnas.1833106100","volume":"100","author":"JS Fowler","year":"2003","unstructured":"Fowler JS, Logan J, Wang GJ, Volkow ND, Telang F, Zhu W et al (2003) Low monoamine oxidase B in peripheral organs in smokers. Proc Natl Acad Sci U S A 100:11600\u201311605","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3823_CR17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1469-8986.2007.00524.x","volume":"44","author":"DR Fuerst","year":"2007","unstructured":"Fuerst DR, Gallinat J, Boutros NN (2007) Range of sensory gating values and test\u2013retest reliability in normal subjects. Psychophysiology 44:620\u2013626","journal-title":"Psychophysiology"},{"key":"3823_CR18","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0013-4694(83)90135-9","volume":"55","author":"G Gratton","year":"1983","unstructured":"Gratton G, Coles MG, Donchin E (1983) A new method for off-line removal of ocular artifact. Electroencephalogr Clin Neurophysiol 55:468\u2013484","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"3823_CR19","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1007\/BF02246225","volume":"106","author":"W Haefely","year":"1992","unstructured":"Haefely W, Burkard WP, Cesura AM, Kettler R, Lorez HP, Martin JR et al (1992) Biochemistry and pharmacology of moclobemide, a prototype RIMA. Psychopharmacol (Berl) 106:S6\u2013S14","journal-title":"Psychopharmacol (Berl)"},{"key":"3823_CR20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1017\/S1461145706007504","volume":"10","author":"TB Hammer","year":"2007","unstructured":"Hammer TB, Oranje B, Glenthoj BY (2007) The effects of imipramine on P50 suppression, prepulse inhibition and habituation of the startle response in humans. Int J Neuropsychopharmacol 10:787\u2013795","journal-title":"Int J Neuropsychopharmacol"},{"key":"3823_CR21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.heares.2004.11.009","volume":"202","author":"AW Harkrider","year":"2005","unstructured":"Harkrider AW, Hedrick MS (2005) Acute effect of nicotine on auditory gating in smokers and non-smokers. Hear Res 202:114\u2013128","journal-title":"Hear Res"},{"key":"3823_CR22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2174\/1568015054863828","volume":"5","author":"K Hashimoto","year":"2005","unstructured":"Hashimoto K, Koike K, Shimizu E, Iyo M (2005) \u03b17 Nicotinic receptor agonists as potential therapeutic drugs for schizophrenia. Curr Med Chem Cent Nerv Sys 5:171\u2013184","journal-title":"Curr Med Chem Cent Nerv Sys"},{"key":"3823_CR23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0006-3223(95)00067-4","volume":"39","author":"WP Hetrick","year":"1996","unstructured":"Hetrick WP, Sandman CA, Bunney WE Jr, Jin Y, Potkin SG, White MH (1996) Gender differences in gating of the auditory evoked potential in normal subjects. Biol Psychiatry 39:51\u201358","journal-title":"Biol Psychiatry"},{"key":"3823_CR24","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1093\/clinchem\/38.10.2087","volume":"38","author":"I Hindberg","year":"1992","unstructured":"Hindberg I, Naesh O (1992) Serotonin concentrations in plasma and variations during the menstrual cycle. Clin Chem 38:2087\u20132089","journal-title":"Clin Chem"},{"unstructured":"Hoffman-La Roche Ltd. (2009) Manerix product monograph. www.rochecanada.com","key":"3823_CR25"},{"key":"3823_CR26","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1177\/0269881111415734","volume":"25","author":"DH Holstein","year":"2011","unstructured":"Holstein DH, Csomor PA, Geyer MA, Huber T, Brugger N, Studerus E et al (2011) The effects of sertindole on sensory gating, sensorimotor gating, and cognition in healthy volunteers. J Psychopharmacol 25:1600\u20131613","journal-title":"J Psychopharmacol"},{"key":"3823_CR27","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.mp.4001443","volume":"9","author":"E Houy","year":"2004","unstructured":"Houy E, Raux G, Thibaut F, Belmont A, Demily C, Allio G et al (2004) The promoter\u2212194 C polymorphism of the nicotinic alpha 7 receptor gene has a protective effect against the P50 sensory gating deficit. Mol Psychiatry 9:320\u2013322","journal-title":"Mol Psychiatry"},{"key":"3823_CR28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1124\/pr.57.1.3","volume":"57","author":"J Hukkanen","year":"2005","unstructured":"Hukkanen J, Jacob P, Benowitz NL (2005) Metabolism and disposition kinetics of nicotine. Pharmacol Rev 57:79\u2013115","journal-title":"Pharmacol Rev"},{"key":"3823_CR29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00213-007-1001-y","volume":"196","author":"KS Jensen","year":"2008","unstructured":"Jensen KS, Oranje B, Wienberg M, Glenth\u00f8j BY (2008) The effects of increased serotonergic activity on human sensory gating and its neural generators. Psychopharmacol (Berl) 196:631\u2013641","journal-title":"Psychopharmacol (Berl)"},{"key":"3823_CR30","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/0006-2952(68)90066-X","volume":"17","author":"J Johnston","year":"1968","unstructured":"Johnston J (1968) Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol 17:1285\u20131292","journal-title":"Biochem Pharmacol"},{"key":"3823_CR31","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.neuroscience.2010.07.012","volume":"170","author":"VJ Knott","year":"2010","unstructured":"Knott VJ, Fisher DJ, Millar AM (2010a) Differential effects of nicotine on P50 amplitude, its gating, and their neural sources in low and high suppressors. Neuroscience 170:816\u2013826","journal-title":"Neuroscience"},{"key":"3823_CR32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuroscience.2009.11.053","volume":"166","author":"V Knott","year":"2010","unstructured":"Knott V, Millar A, Fisher D, Albert P (2010b) Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism. Neuroscience 166:145\u2013156","journal-title":"Neuroscience"},{"key":"3823_CR33","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1177\/0269881113490449","volume":"27","author":"V Knott","year":"2013","unstructured":"Knott V, de la Salle S, Smith D, Phillipe T, Dort H, Choueiry J et al (2013) Baseline dependency of nicotine\u2019s sensory gating actions: similarities and differences in low, medium and high P50 suppressors. J Psychopharmacol 27:790\u2013800","journal-title":"J Psychopharmacol"},{"key":"3823_CR34","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.neubiorev.2005.02.006","volume":"29","author":"V Kumari","year":"2005","unstructured":"Kumari V, Postma P (2005) Nicotine use in schizophrenia: the self medication hypotheses. Neurosci Biobehav Rev 29:1021\u20131034","journal-title":"Neurosci Biobehav Rev"},{"key":"3823_CR35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/1471-2458-9-285","volume":"9","author":"D Lawrence","year":"2009","unstructured":"Lawrence D, Mitrou F, Zubrick SR (2009) Smoking and mental illness: results from population surveys in Australia and the United States. BMC Public Health 9:285","journal-title":"BMC Public Health"},{"key":"3823_CR36","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuro.2006.05.019","volume":"28","author":"A Lewis","year":"2007","unstructured":"Lewis A, Miller JH, Lea RA (2007) Monoamine oxidase and tobacco dependence. Neurotoxicology 28:182\u2013195","journal-title":"Neurotoxicology"},{"key":"3823_CR37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1566-2772(03)00018-5","volume":"3","author":"GA Light","year":"2003","unstructured":"Light GA, Braff DL (2003) Sensory gating deficits in schizophrenia: can we parse the effects of medication, nicotine use, and changes in clinical status? Clin Neur Res 3:47\u201354","journal-title":"Clin Neur Res"},{"key":"3823_CR38","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0006-3223(99)00034-7","volume":"46","author":"GA Light","year":"1999","unstructured":"Light GA, Malaspina D, Geyer MA, Luber BM, Coleman EA, Sackeim HA et al (1999) Amphetamine disrupts P50 suppression in normal subjects. Biol Psychiatry 46:990\u2013996","journal-title":"Biol Psychiatry"},{"key":"3823_CR39","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1469-8986.2006.00478.x","volume":"44","author":"BY Lu","year":"2007","unstructured":"Lu BY, Edgar JC, Jones AP, Smith AK, Huang MX, Miller GA et al (2007) Improved test\u2013retest reliability of 50\u00a0ms paired click auditory gating using magnetoencephalography source modeling. Psychophysiology 44:86\u201390","journal-title":"Psychophysiology"},{"key":"3823_CR40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0006-8993(92)91437-J","volume":"587","author":"V Luntz-Leybman","year":"1992","unstructured":"Luntz-Leybman V, Bickford PC, Freedman R (1992) Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res 587:130\u2013136","journal-title":"Brain Res"},{"key":"3823_CR41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1037\/1082-989X.7.1.19","volume":"7","author":"RC MacCallum","year":"2002","unstructured":"MacCallum RC, Zhang S, Preacher KJ, Rucker DD (2002) On the practice of dichotomization of quantitative variables. Psychol Methods 7:19","journal-title":"Psychol Methods"},{"key":"3823_CR42","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/sj.npp.1301556","volume":"33","author":"C Mann","year":"2007","unstructured":"Mann C, Croft RJ, Scholes KE, Dunne A, O\u2019Neill BV, Leung S et al (2007) Differential effects of acute serotonin and dopamine depletion on prepulse inhibition and P50 suppression measures of sensorimotor and sensory gating in humans. Neuropsychopharmacology 33:1653\u20131666","journal-title":"Neuropsychopharmacology"},{"key":"3823_CR43","volume-title":"Family Interview for Genetic Studies (FIGS): a manual for FIGS","author":"ME Maxwell","year":"1992","unstructured":"Maxwell ME (1992) Family Interview for Genetic Studies (FIGS): a manual for FIGS. Clinical Neurogenetics Branch, Intramural Research Program, National Institute of Mental Health, Bethesda"},{"key":"3823_CR44","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neuroscience.2011.02.008","volume":"180","author":"A Millar","year":"2011","unstructured":"Millar A, Smith D, Choueiry J, Fisher D, Albert P, Knott V (2011) The moderating role of the dopamine transporter 1 gene on P50 sensory gating and its modulation by nicotine. Neuroscience 180:148\u2013156","journal-title":"Neuroscience"},{"key":"3823_CR45","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00422-002-0372-8","volume":"88","author":"KA Moxon","year":"2003","unstructured":"Moxon KA, Gerhardt GA, Adler LE (2003) Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia. Biol Cybern 88:265\u2013275","journal-title":"Biol Cybern"},{"key":"3823_CR46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.coph.2003.11.001","volume":"4","author":"PA Newhouse","year":"2004","unstructured":"Newhouse PA, Potter A, Singh A (2004) Effects of nicotinic stimulation on cognitive performance. Curr Opin Pharmacol 4:36\u201346","journal-title":"Curr Opin Pharmacol"},{"key":"3823_CR47","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/schbul\/sbt144","volume":"40","author":"B Oranje","year":"2014","unstructured":"Oranje B, Glenth\u00f8j BY (2014) Clonidine normalizes levels of P50 gating in patients with schizophrenia on stable medication. Schizophr Bull 40:1022\u20131029","journal-title":"Schizophr Bull"},{"key":"3823_CR48","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.psychres.2010.09.019","volume":"186","author":"B Oranje","year":"2011","unstructured":"Oranje B, Wienberg M, Glenthoj BY (2011) A single high dose of escitalopram disrupts sensory gating and habituation, but not sensorimotor gating in healthy volunteers. Psychiatry Res 186:431\u2013436","journal-title":"Psychiatry Res"},{"key":"3823_CR49","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/0024-3205(81)90706-2","volume":"29","author":"L Oreland","year":"1981","unstructured":"Oreland L, Fowler CJ, Schalling D (1981) Low platelet monoamine oxidase activity in cigarette smokers. Life Sci 29:2511\u20132518","journal-title":"Life Sci"},{"doi-asserted-by":"crossref","unstructured":"Patterson JV, Hetrick WP, Boutros NN, Jin Y, Sandman C, Stern H et al (2008) P50 sensory gating ratios in schizophrenics and controls: a review and data analysis. Psychiatry Res 158:226\u2013247","key":"3823_CR50","DOI":"10.1016\/j.psychres.2007.02.009"},{"key":"3823_CR51","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00213-002-1237-5","volume":"165","author":"J Riba","year":"2002","unstructured":"Riba J, Rodr\u00edguez-Fornells A, Barbanoj MJ (2002) Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively. Psychopharmacol (Berl) 165:18\u201328","journal-title":"Psychopharmacol (Berl)"},{"key":"3823_CR52","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/14622200110087277","volume":"3","author":"JE Rose","year":"2001","unstructured":"Rose JE, Behm FM, Ramsey C, Ritchie JC Jr (2001) Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms. Nicotine Tob Res 3:383\u2013390","journal-title":"Nicotine Tob Res"},{"key":"3823_CR53","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0306-4522(96)83013-2","volume":"70","author":"J Saura","year":"1996","unstructured":"Saura J, Bleuel Z, Ulrich J, Mendelowitsch A, Chen K, Shih JC et al (1996) Molecular neuroanatomy of human monoamine oxidases A and B revealed by quantitative enzyme radioautography and in situ hybridization histochemistry. Neuroscience 70:755\u2013774","journal-title":"Neuroscience"},{"key":"3823_CR54","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.neuro.22.1.197","volume":"22","author":"JC Shih","year":"1999","unstructured":"Shih JC, Chen K, Ridd MJ (1999) Monoamine oxidase: from genes to behavior. Annu Rev Neurosci 22:197\u2013217","journal-title":"Annu Rev Neurosci"},{"key":"3823_CR55","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0893-133X(95)00178-G","volume":"15","author":"KE Stevens","year":"1996","unstructured":"Stevens KE, Freedman R, Collins AC, Hall M, Leonard S, Marks MJ et al (1996) Genetic correlation of inhibitory gating of hippocampal auditory evoked response and \u03b1-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Neuropsychopharmacology 15:152\u2013162","journal-title":"Neuropsychopharmacology"},{"key":"3823_CR56","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/0006-2952(90)90242-D","volume":"40","author":"EC Twist","year":"1990","unstructured":"Twist EC, Brammer MJ, Stephenson JD, Corn TH, Campbell IC (1990) The effect of chronic ritanserin and clorgyline administration on 5-HT2 receptor linked inositol phospholipid hydrolysis. Biochem Pharmacol 40:2111\u20132116","journal-title":"Biochem Pharmacol"},{"key":"3823_CR57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/14622200050011277","volume":"2","author":"SS Watkins","year":"2000","unstructured":"Watkins SS, Koob GF, Markou A (2000) Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal. Nicotine Tob Res 2:19\u201337","journal-title":"Nicotine Tob Res"},{"key":"3823_CR58","first-page":"91","volume":"28","author":"KA Wesnes","year":"1988","unstructured":"Wesnes KA, Simpson PM, Christmas L, Anand R, McClelland GR (1988) The effects of moclobemide on cognition. J Neural Transm Suppl 28:91\u2013102","journal-title":"J Neural Transm Suppl"},{"key":"3823_CR59","first-page":"137","volume":"54","author":"W Weyler","year":"1976","unstructured":"Weyler W, Hsu Y, Breakefield X (1976) Biochemistry and genetics of monoamine oxidase. Pharmacol Ther 54:137\u2013141","journal-title":"Pharmacol Ther"},{"key":"3823_CR60","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0161-813X(03)00097-4","volume":"25","author":"M Yamada","year":"2004","unstructured":"Yamada M, Yasuhara H (2004) Clinical pharmacology of MAO inhibitors: safety and future. NeuroToxicology 25:215\u2013221","journal-title":"NeuroToxicology"},{"key":"3823_CR61","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1038\/sj.bjp.0706464","volume":"147","author":"MB Youdim","year":"2006","unstructured":"Youdim MB, Bakhle YS (2006) Monoamine oxidase: isoforms and inhibitors in Parkinson\u2019s disease and depressive illness. Br J Pharmacol 147:S287\u2013S296","journal-title":"Br J Pharmacol"},{"key":"3823_CR62","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrn1883","volume":"7","author":"MB Youdim","year":"2006","unstructured":"Youdim MB, Edmondson D, Tipton KF (2006) The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci 7:295\u2013309","journal-title":"Nat Rev Neurosci"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-014-3823-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-014-3823-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-014-3823-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T22:41:04Z","timestamp":1747176064000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-014-3823-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,4]]},"references-count":62,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["3823"],"URL":"https:\/\/doi.org\/10.1007\/s00213-014-3823-8","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"type":"print","value":"0033-3158"},{"type":"electronic","value":"1432-2072"}],"subject":[],"published":{"date-parts":[[2014,12,4]]}}}